Imagia Canexia Health’s Follow It panel detects mutations in plasma. Plasma profiling (a type of liquid biopsy) can be used to help tailor treatment, monitor cancer progression, or detect treatment resistance.
Targeted cancer treatment can improve patient outcomes two- to three-fold. Genetic biomarker testing helps oncologists identify targeted treatments based on tumor DNA analysis. Canexia Health’s genomic testing solutions, including assays and concise reporting, provide cancer professionals with insights to aid targeted treatment decisions.
After a patient sample is received, report turnaround is 10 days. This turnaround time allows oncologists to implement effective treatment plans within a meaningful timeframe that could have a significant impact on a patient’s clinical outcome.